Evidence map›Paper›PMID 27086544›Full record

ArticleBiological psychiatry2016

Receptor Tyrosine Kinase MET Interactome and Neurodevelopmental Disorder Partners at the Developing Synapse.

Zhihui Xie, Jing Li, Jonathan Baker, Kathie L Eagleson, Marcelo P Coba, Pat Levitt

Open access · greenAbstract read
In one paragraph

Article in Biological psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. NMDA Receptor and Its Emerging Role in Cancer.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Distinct Properties of Layer 3 Pyramidal Neurons from Prefrontal and Parietal Areas of the Monkey Neocortex.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Zhihui XieDepartment of Pediatrics and The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California.
Jing LiZilkha Neurogenetic Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Jonathan BakerCollege of Science, University of Notre Dame, South Bend, Indiana.
Kathie L EaglesonDepartment of Pediatrics, Children's Hospital Los Angeles and the Keck School of Medicine of the University of Southern California; Los Angeles, California.
Marcelo P CobaZilkha Neurogenetic Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Pat LevittDepartment of Pediatrics, Children's Hospital Los Angeles and the Keck School of Medicine of the University of Southern California; Los Angeles, California; Program in Developmental Neurogenetics, Institute for the Developing Mind and The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California. Electronic address: plevitt@med.usc.edu.
University of Southern California · USChildren's Hospital of Los Angeles · USUniversity of Notre Dame · US

Funding

Function &Structure Adaptation in Forebrain DevelopmentR01MH067842 · NIMH · VANDERBILT UNIVERSITY · PI LEVITT, PAT · 2002 to 2023
$10.8M
Function and Structure Adaptations in Forebrain DevelopmentR56MH067842 · NIMH · CHILDREN'S HOSPITAL OF LOS ANGELES · PI LEVITT, PAT · 2014 to 2014
$662k
NIMH NIH HHS R01 MH067842NIMH NIH HHS R56 MH067842
6 · The paper itself

Abstract

backgroundAtypical synapse development and plasticity are implicated in many neurodevelopmental disorders (NDDs). NDD-associated, high-confidence risk genes have been identified, yet little is known about functional relationships at the level of protein-protein interactions, which are the dominant molecular bases responsible for mediating circuit development.

methodsProteomics in three independent developing neocortical synaptosomal preparations identified putative interacting proteins of the ligand-activated MET receptor tyrosine kinase, an autism risk gene that mediates synapse development. The candidates were translated into interactome networks and analyzed bioinformatically. Additionally, three independent quantitative proximity ligation assays in cultured neurons and four independent immunoprecipitation analyses of synaptosomes validated protein interactions.

resultsApproximately 11% (8/72) of MET-interacting proteins, including SHANK3, SYNGAP1, and GRIN2B, are associated with NDDs. Proteins in the MET interactome were translated into a novel MET interactome network based on human protein-protein interaction databases. High-confidence genes from different NDD datasets that encode synaptosomal proteins were analyzed for being enriched in MET interactome proteins. This was found for autism but not schizophrenia, bipolar disorder, major depressive disorder, or attention-deficit/hyperactivity disorder. There is correlated gene expression between MET and its interactive partners in developing human temporal and visual neocortices but not with highly expressed genes that are not in the interactome. Proximity ligation assays and biochemical analyses demonstrate that MET-protein partner interactions are dynamically regulated by receptor activation.

conclusionsThe results provide a novel molecular framework for deciphering the functional relations of key regulators of synaptogenesis that contribute to both typical cortical development and to NDDs.

Indexed as

Cells, CulturedHumansNeocortexNeurodevelopmental DisordersNeurogenesisNeuronsProtein Interaction MapsProteomicsProto-Oncogene Proteins c-metSynapsesMET protein, humanProto-Oncogene Proteins c-metAutismInteractomeMental illnessesNeocortexProteomicsSynaptogenesis

Identifiers

PMID27086544
PMCPMC5001930
OpenAlexW2274267270

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.